title: Clinical Experience with Lapatinib in Patients with ErbB2-Overexpressing Metastatic Breast Cancer.
authors.affiliation: Frauenklinik der Technischen Universität München, Klinikum Rechts der Isar, Berlin, Germany.
authors.forename: Nadia
authors.initials: N
authors.lastname: Harbeck
authors.forename: Volker
authors.initials: V
authors.lastname: Heinemann
authors.forename: Sibylle
authors.initials: S
authors.lastname: Loibl
authors.forename: Michael
authors.initials: M
authors.lastname: Untch
references.citation: Br J Cancer. 2006 Jan 30;94(2):259-67
references.pmid: 16404427
references.citation: EMBO J. 2000 Jul 3;19(13):3159-67
references.pmid: 10880430
references.citation: Cancer Res. 2007 Feb 1;67(3):1170-5
references.pmid: 17283152
references.citation: Nat Rev Cancer. 2005 May;5(5):341-54
references.pmid: 15864276
references.citation: J Clin Oncol. 2005 Aug 10;23(23):5305-13
references.pmid: 15955900
references.citation: Oncogene. 2004 Jan 22;23(3):646-53
references.pmid: 14737100
references.citation: Oncologist. 2003;8(1):5-17
references.pmid: 12604728
references.citation: Br J Cancer. 2004 Aug 16;91(4):639-43
references.pmid: 15266327
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15
references.pmid: 11597399
references.citation: Drug Discov Today. 2007 Jan;12(1-2):54-61
references.pmid: 17198973
references.citation: Cancer Res. 1998 Nov 15;58(22):5123-9
references.pmid: 9823322
references.citation: Cancer. 2004 Mar 1;100(5):920-8
references.pmid: 14983486
references.citation: Cancer Res. 2005 Dec 1;65(23):10992-1000
references.pmid: 16322248
references.citation: Oncologist. 2006 Nov-Dec;11(10):1047-57
references.pmid: 17110623
references.citation: Br J Cancer. 2006 Jan 30;94(2):247-52
references.pmid: 16404430
references.citation: Cancer Res. 2001 Oct 1;61(19):7196-203
references.pmid: 11585755
references.citation: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references.pmid: 11252954
references.citation: Cancer Cell. 2007 Oct;12(4):395-402
references.pmid: 17936563
references.citation: Oncologist. 2004;9 Suppl 3:10-5
references.pmid: 15163842
references.citation: Drugs Today (Barc). 2006 Jul;42(7):441-53
references.pmid: 16894399
references.citation: Breast Cancer Res Treat. 2008 Dec;112(3):533-43
references.pmid: 18188694
references.citation: Clin Cancer Res. 2006 Jan 15;12(2):424-31
references.pmid: 16428482
references.citation: Oncologist. 2007 Jul;12(7):756-65
references.pmid: 17673607
references.citation: N Engl J Med. 2006 Dec 28;355(26):2733-43
references.pmid: 17192538
references.citation: Cancer Cell. 2004 Aug;6(2):117-27
references.pmid: 15324695
references.citation: Cancer Res. 2005 Apr 1;65(7):2554-9
references.pmid: 15805248
references.citation: Cancer. 2003 Jun 15;97(12):2972-7
references.pmid: 12784331
references.citation: Cancer. 2006 Aug 15;107(4):696-704
references.pmid: 16826579
references.citation: Ann Pharmacother. 2006 Feb;40(2):261-9
references.pmid: 16418322
references.citation: J Clin Oncol. 2005 Mar 20;23(9):1941-50
references.pmid: 15774787
references.citation: Clin Cancer Res. 2004 Sep 1;10(17):5650-5
references.pmid: 15355889